Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Trial of ZF2001 Vaccine in Adults Aged 60 and Older
NCT04550351Phase 1Unknown
- Sponsor
- Zhifei Biological
- Start
- Aug 2020
- Primary completion
- Dec 2020
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ZF2001 in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Zhifei Biological. Primary endpoints: Incidence of adverse events, Incidence of serious adverse events and 1 more. Status: unknown.
02
Drugs
ZF2001
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04550351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04550351.